Orexigen Therapeutics, Inc. News Headlines

Get OREX Alerts
*Delayed - data as of Oct. 21, 2014 9:50 ET  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
Orexigen: Poised To Grab A Large Part Of The Weight Loss Market
9/12/2014 1:40:00 PM - Seeking Alpha

Belviq Advertising Sees Major Shift
9/12/2014 1:22:00 PM - Seeking Alpha

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr
9/12/2014 9:09:40 AM - Motley Fool

A New Nifty Fifty States Stock Index
9/12/2014 12:46:00 AM - Seeking Alpha

FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug
9/11/2014 4:46:01 PM - Motley Fool

Sector Update: Health Care Stocks Sit Out Late Rise For Stocks; Orexigen Slammed After FDA 'Black Label'
9/11/2014 4:04:37 PM - MT Newswires

Sector Update: Health Care
9/11/2014 4:02:39 PM - MT Newswires

Skinny pill approved!
9/11/2014 11:32:00 AM - Market Intelligence Center

Orexigen's Contrave Approved: What It Means To Arena
9/11/2014 10:02:00 AM - Seeking Alpha

FDA Approves Orexigen's Contrave For Obesity Treatment
9/11/2014 9:22:00 AM - Seeking Alpha

Sector Update: Health Care
9/11/2014 8:38:24 AM - MT Newswires

Sector Update: Healthcare shares Mixed in Pre-Market Trade
9/11/2014 8:37:28 AM - MT Newswires

FDA Approves Orexigen's Diet Drug Contrave
9/11/2014 8:35:00 AM - Dow Jones Business News

FDA Okays Orexigen Therapeutics' Weight-Loss Drug Contrave
9/11/2014 6:07:00 AM - RTT News

Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014
9/9/2014 9:45:02 AM - Motley Fool

Orexigen Gets Weight Loss Drug Patent, May See Runup Into Approval Decision
9/5/2014 11:46:00 AM - Seeking Alpha

Belviq Sales Crack Critical Level
8/29/2014 4:46:00 PM - Seeking Alpha

Vivus Acquires Patent Rights To Qsymia Ingredient
8/25/2014 1:38:00 PM - Seeking Alpha

Belviq Sales Rise 2%
8/25/2014 9:57:00 AM - Seeking Alpha

Belviq Sales Flatten Out But Edge Above Qsymia
8/15/2014 4:10:00 PM - Seeking Alpha

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain
8/8/2014 1:28:00 PM - Seeking Alpha

Vivus Beats The Street - Still Has A Loss
8/8/2014 10:04:00 AM - Seeking Alpha

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com

Orexigen Hits Expectations But That Is Not The Big News
8/7/2014 1:25:00 PM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha